• Explore /
  • Poster
  • / Elucidation of PARP inhibitor activity in BRCAwt recurrent ovarian cancer by hrr mutational gene profile analysis.

Elucidation of PARP inhibitor activity in BRCAwt recurrent ovarian cancer by hrr mutational gene profile analysis.

Abstract Poster

Authors

Mansoor Mirza

Mansoor Raza Mirza

Nordic Society of Gynecologic Oncology (NSGO) and Rigshospitalet University Hospital, Copenhagen, Denmark

Mansoor Raza Mirza , Bin Feng , Ming Shan , Kaiming Sun , Ilkar Yalcin , Kevin Coleman , Kenneth S. Thress , Sebastien Hazard , Jing Y. Wang , Ursula A. Matulonis

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gynecologic Cancer

Track

Gynecologic Cancer

Sub Track

Ovarian Cancer

Citation

J Clin Oncol 37, 2019 (suppl; abstr 5568)

DOI

10.1200/JCO.2019.37.15_suppl.5568

Abstract #

5568

Poster Bd #

391

Abstract Disclosures

Similar Posters

Poster

2017 ASCO Annual Meeting

Long-term benefit of niraparib treatment of recurrent ovarian cancer (OC).

Long-term benefit of niraparib treatment of recurrent ovarian cancer (OC).

First Author: Ursula A. Matulonis

First Author: Lorena Incorvaia

First Author: Ainhoa Madariaga

First Author: Kathleen N. Moore